Evaluation of perfusion modes on vital organ recovery and thyroid hormone homeostasis in pediatric patients undergoing cardiopulmonary bypass

Artificial Organs

Volumn 34, Issue 11, 2010, Pages 879-884

  Akçevin, Atif ^a   Alkan Bozkaya, Tijen ^a   Qiu, Feng ^b   Ündar, Akif ^b  

^a ISTANBUL BILIM UNIVERSITY   (Turkey)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Cardiopulmonary bypass; Congenital heart defect; Pediatric; Pulsatile perfusion; Thyroid hormone levels; Vital organ recovery

Indexed keywords

AMINO ACIDS; BLOOD PRESSURE; BODY FLUIDS; ENDOCRINOLOGY; ENZYMES; HEART; HORMONES; INTENSIVE CARE UNITS; PEDIATRICS;

4-LEVEL; CARDIOPULMONARY BYPASS; CONGENITAL HEART DEFECTS; HOMOEOSTASIS; HORMONE LEVELS; PEDIATRIC PATIENTS; THYROID HORMONE LEVEL; THYROID HORMONES; THYROID STIMULATING HORMONES; VITAL ORGAN RECOVERY;

RECOVERY;

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; LACTIC ACID; LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOPULMONARY BYPASS; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEART SURGERY; HEMATOCRIT; HOMEOSTASIS; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE UNIT; INTUBATION; LEUKOCYTE COUNT; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEWBORN; ORGAN PERFUSION; OUTCOME ASSESSMENT; PEDIATRICS; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSATILE FLOW; SCHOOL CHILD; SURGICAL DRAINAGE; SURVIVAL; THROMBOCYTE COUNT; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; URINE VOLUME;

EID: 78649538447     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01159.x     Document Type: Article

References (24)

1. Ündar A. Pulsatile versus nonpulsatile cardiopulmonary bypass procedures in neonates and infants: from bench to clinical practice. ASAIO J 2005;51:vi-x.
2. Wernovsky G. Current insights regarding neurological and developmental abnormalities in children and young adults with complex congenital cardiac disease. Cardiol Young 2006;16(Suppl 1):92-104.
3. Su XW, Ündar A. Brain protection during pediatric cardiopulmonary bypass. Artif Organs 2010;34:E91-E102.
4. Wang S, Haines N, Ündar A. Hemodynamic energy delivery of the pulsatile flow in a simulated pediatric extracorporeal circuit. ASAIO J 2009;55:96-9.
5. Rider AR, Ressler NM, Karkhanis TR, Kunselman AR, Wang S, Ündar A. The impact of pump settings on the quality of pulsatility. ASAIO J 2009;55:100-5.
6. Ündar A, Masai T, Yang SQ, Goddard-Finegold J, Frazier OH, Fraser CD Jr. Effects of perfusion mode on regional and global organ blood flow in a neonatal piglet model. Ann Thorac Surg 1999;68:1336-42.
7. Ündar A, Eichstaedt HC, Bigley JE Jr, et al. Effects of pulsatile and nonpulsatile perfusion on cerebral hemodynamics investigated with a new pediatric pump. J Thorac Cardiovasc Surg 2002;124:413-6.
8. Singal RK, Docking LM, Girling LG, et al. Biologically variable bypass reduces enzymuria after deep hypothermic circulatory arrest. Ann Thorac Surg 2006;82:1480-8.
9. Zhao J, Liu JP, Feng ZY, Liu YL, Li SJ, Long C. Clinical application of pulsatile perfusion during cardiopulmonary bypass in pediatric heart surgery. ASAIO J 2009;55:300-3.
10. Siepe M, Goebel U, Mecklenburg A, et al. Pulsatile pulmonary perfusion during cardiopulmonary bypass reduces the pulmonary inflammatory response. Ann Thorac Surg 2008;86:115-22.
11. Voss B, Krane M, Jung C, et al. Cardiopulmonary bypass with physiological flow and pressure curves: pulse is unnecessary! Eur J Cardiothorac Surg 2010;37:223-32.
12. Alkan T, Akçevin A, Ündar A, Türkoǧlu H, Paker T, Aytaç A. Effects of pulsatile and nonpulsatile perfusion on vital organ recovery in pediatric heart surgery: a pilot clinical study. ASAIO J 2006;52:530-5.
13. Alkan T, Akçevin A, Ündar A, Türkoǧlu H, Paker T, Aytaç A. Benefits of pulsatile perfusion on vital organ recovery during and after pediatric open heart surgery. ASAIO J 2007;53:651-4.
14. Murzi B, Iervasi G, Masini S, et al. Thyroid hormones homeostasis in pediatric patients during and after cardiopulmonary bypass. Ann Thorac Surg 1995;59:481-5.
15. Alghamdi AA, Latter DA. Pulsatile versus nonpulsatile cardiopulmonary bypass flow: an evidence-based approach. J Card Surg 2006;21:347-54.
16. Haines N, Wang S, Ündar A, Alkan T, Akçevin A. Clinical outcomes of pulsatile and non-pulsatile mode of perfusion. J Extra Corpor Technol 2009;41:26-9.
17. Talor J, Yee S, Rider A, Kunselman AR, Guan Y, Ündar A. Comparison of perfusion quality in hollow-fiber membrane oxygenators for neonatal extracorporeal life support. Artif Organs 2010;34:E110-16.
18. Rider AR, Ji B, Kunselman AR, Weiss WJ, Myers JL, Ündar A. A performance evaluation of eight geometrically different 10 Fr pediatric arterial cannulae under pulsatile and nonpulsatile perfusion conditions in an infant cardiopulmonary bypass model. ASAIO J 2008;54:306-15.
19. Sezai A, Shiono M, Nakata K, et al. Effects of pulsatile CPB on interleukin-8 and endothelin-1 levels. Artif Organs 2005;29:708-13.
20. Klemperer JD. Thyroid hormone and cardiac surgery. Thyroid 2002;12:517-21.
21. Plumpton K, Nikolaus AH. Identifying infants at risk of marked thyroid suppression post-cardiopulmonary bypass. Intensive Care Med 2005;31:581-7.
22. Nikolaus AH, Camphausen CK, Kececioglu D. Clinical review: thyroid hormone replacement in children after cardiac surgery-is it worth a try? Crit Care 2006;10:213-27.
23. Durandy YD, Younes M, Mahut B. Pediatric warm open heart surgery and prolonged cross-clamp time. Ann Thorac Surg 2008;86:1941-7.
24. Jenkins KJ. Risk adjustment for congenital heart surgery: the RACHS-1 method. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004;7:180-4.